Former Home Diagnostics CEO Admits To Insider Trading

Law360, New York (August 8, 2012, 6:51 PM EDT) -- The former head of Home Diagnostics Inc. pled guilty to insider trading mid-trial Wednesday, admitting he encouraged friends and family to buy stock in his company before it was purchased by medical device maker Nipro Corp. for $215 million. 

George Holley copped to two counts of insider trading after the defense rested its case in the trial, according to the office of the U.S. Attorney for the District of New Jersey. 

Holley was accused of disclosing nonpublic information about the sale of Home Diagnostics, which he...
To view the full article, register now.